Lungwort (Pulmonaria officinalis)

Lungwort (Pulmonaria officinalis) contains phenolic acids and mucilage compounds that provide antioxidant and expectorant properties. The herb's phenolic acid fractions demonstrate radical-scavenging activity while mucilage compounds help soothe respiratory tract inflammation.

Origin & History

Lungwort (Pulmonaria officinalis) is a perennial herbaceous plant in the Boraginaceae family, native to Europe and parts of Asia, with aerial parts (leaves) primarily used medicinally. The dried leaves are typically extracted using water, ethanol, or alcohol-glycerin mixtures to yield aqueous, ethanolic, or tincture forms.

Historical & Cultural Context

In European traditional medicine, lungwort has been used for centuries as an emollient, expectorant, and anti-inflammatory herb for respiratory conditions like coughs and bronchitis. The herb's use was influenced by the doctrine of signatures due to its lung-like spotted leaves.

Health Benefits

• Antioxidant activity demonstrated in vitro through phenolic acid fractions showing radical-scavenging properties (preliminary evidence only)
• Traditional respiratory support as an expectorant for coughs and bronchitis (traditional use evidence only)
• Anti-inflammatory effects claimed in traditional medicine (no clinical evidence)
• Emollient properties for soothing irritated tissues (traditional use only)
• Potential lung health support based on historical doctrine of signatures (no scientific validation)

How It Works

Lungwort's phenolic acid compounds, including caffeic acid and chlorogenic acid, neutralize free radicals through electron donation and metal chelation pathways. The herb's mucilage polysaccharides coat and soothe irritated respiratory mucosa while potentially modulating inflammatory cytokine production. These mechanisms support both antioxidant protection and respiratory tract comfort.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses on Pulmonaria officinalis were identified. Research is limited to phytochemical profiling and in vitro antioxidant studies on extracts, with no published clinical outcomes or PubMed-indexed human studies available.

Clinical Summary

Current evidence for lungwort consists primarily of in vitro antioxidant studies demonstrating radical-scavenging activity of phenolic acid fractions, though specific sample sizes and quantified outcomes are limited in available literature. Traditional use evidence supports respiratory applications, but controlled human clinical trials are lacking. Most available research focuses on phytochemical analysis rather than therapeutic efficacy. The evidence strength remains preliminary and requires further investigation through randomized controlled trials.

Nutritional Profile

Lungwort (Pulmonaria officinalis) is a medicinal herb consumed primarily as a tea or tincture rather than a food source, so macronutrient content is of limited practical relevance. Dried herb material contains approximately 10-15% moisture, with the dry weight comprising roughly 8-12% protein, 3-5% lipids, and 40-55% carbohydrates including structural polysaccharides. Crude fiber content is estimated at 15-20% of dry weight. Key bioactive compounds include: phenolic acids dominated by rosmarinic acid (reported at approximately 0.5-2.0% dry weight), chlorogenic acid, and caffeic acid derivatives, which account for the demonstrated radical-scavenging activity. Pyrrolizidine alkaloids (PAs) including intermedine and lycopsamine have been detected at low levels (reported in the range of 0.01-0.1% dry weight depending on plant part and harvest time), representing a safety concern with prolonged use. Tannins are present at approximately 5-10% dry weight, contributing astringent properties. Mucilaginous polysaccharides (estimated 3-8% dry weight) are responsible for the emollient and expectorant traditional uses. Allantoin has been identified at trace levels. Mineral content includes silica, potassium, and calcium at modest concentrations typical of leafy herbs. Vitamin C has been reported in fresh leaf material at low concentrations (approximately 20-40 mg per 100g fresh weight). Bioavailability of phenolic acids from aqueous tea preparations is moderate; PA alkaloids are readily absorbed orally, which is the primary safety concern limiting long-term use.

Preparation & Dosage

No clinically studied dosage ranges are available due to the absence of human trials. Topical dry extracts are regulated with ratios of 2:1 to 20:1, equivalent to at least 250 mg per formulation, but without standardization for active compounds. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Thyme, Marshmallow root, Mullein, Licorice root, Ivy leaf

Safety & Interactions

Lungwort is generally considered safe for short-term traditional use, though comprehensive safety data is limited. No significant drug interactions have been documented, but caution is advised with anticoagulant medications due to potential mucilage effects on drug absorption. Allergic reactions may occur in individuals sensitive to plants in the Boraginaceae family. Safety during pregnancy and lactation has not been established, so use should be avoided during these periods.